Published in Mol Psychiatry on April 01, 2003
The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet (2005) 1.70
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci U S A (2006) 1.40
Attention-Deficit Hyperactivity Disorder in the post-genomic era. Eur Child Adolesc Psychiatry (2004) 1.36
Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet (2005) 1.08
Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors. Int J Environ Res Public Health (2011) 1.01
The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors. PLoS One (2010) 0.91
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART). Postgrad Med (2009) 0.90
No evidence for the association of DRD4 with ADHD in a Taiwanese population within-family study. BMC Med Genet (2005) 0.89
Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. Neuropsychopharmacology (2010) 0.87
Cognitive effects of nicotine: genetic moderators. Addict Biol (2010) 0.85
Modeling brain dynamics using computational neurogenetic approach. Cogn Neurodyn (2008) 0.83
Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder. BMC Psychiatry (2009) 0.82
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. Pharmgenomics Pers Med (2010) 0.79
Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. Med Hypotheses (2014) 0.78
ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine. Dialogues Clin Neurosci (2006) 0.78
Advances in molecular genetic studies of attention deficit hyperactivity disorder in China. Shanghai Arch Psychiatry (2014) 0.77
Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2012) 0.77
ADHD among adolescents with intellectual disabilities: pre-pathway influences. Res Dev Disabil (2013) 0.77
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. Eur J Neurosci (2016) 0.76
Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice. BMC Complement Altern Med (2017) 0.75
Association study of dopamine transporter gene (DAT1) variable tandem repeat sequence (VNTR) with obsessive-compulsive disorder in Chinese Han Population. Int J Clin Exp Med (2015) 0.75
Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese population. Behav Brain Funct (2014) 0.75
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry (1994) 4.40
Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet (2000) 3.69
Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry (2004) 3.54
DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet (2003) 3.42
Statistical methods of estimation and inference for functional MR image analysis. Magn Reson Med (1996) 3.13
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet (1991) 2.74
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br J Psychiatry (1996) 2.42
Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal study. Mol Psychiatry (2012) 2.37
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatr Scand (2004) 2.24
Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun (2003) 2.23
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21
Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry (2012) 2.20
Equivalence between Haseman-Elston and variance-components linkage analyses for sib pairs. Am J Hum Genet (2001) 2.16
Genetic influence on language delay in two-year-old children. Nat Neurosci (1998) 2.06
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus (2007) 2.03
Psychopathological syndromes and familial morbid risk of psychosis. Br J Psychiatry (1997) 2.02
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
Proteome-based plasma biomarkers for Alzheimer's disease. Brain (2006) 1.98
PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc Res (2007) 1.97
Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry (2005) 1.91
A genome-wide scan of 1842 DNA markers for allelic associations with general cognitive ability: a five-stage design using DNA pooling and extreme selected groups. Behav Genet (2001) 1.86
Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol Psychiatry (2011) 1.84
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 1.80
Transmission/disequilibrium tests for multiallelic loci. Am J Hum Genet (1997) 1.72
Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clin Genet (2010) 1.71
Co-occurrence of ADHD and low IQ has genetic origins. Am J Med Genet B Neuropsychiatr Genet (2004) 1.69
Isolation and characterization of eight lipid A precursors from a 3-deoxy-D-manno-octylosonic acid-deficient mutant of Salmonella typhimurium. J Biol Chem (1985) 1.67
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry (2010) 1.63
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Prenatal exposure to influenza and the development of schizophrenia: is the effect confined to females? Am J Psychiatry (1994) 1.55
A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet (1996) 1.55
Seasonality of admissions in the psychoses: effect of diagnosis, sex, and age at onset. Br J Psychiatry (1992) 1.53
Molecular requirements for B-lymphocyte activation by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1983) 1.51
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. Eur J Cancer (2002) 1.49
A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychol Med (2007) 1.49
The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry (2011) 1.46
Association analysis of mild mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Mol Psychiatry (2005) 1.46
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2006) 1.46
Obstetric complications in patients with schizophrenia and their unaffected siblings. Eur Psychiatry (2005) 1.45
Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry (2005) 1.44
Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus? Schizophr Res (1995) 1.44
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Traumatic neuroma of mental nerve following chin augmentation. Int J Oral Maxillofac Surg (2009) 1.40
Response to Yaryura-Tobias et al (2000) negative outcome after neurosurgery for refractory obsessive-compulsive spectrum disorder, World J Biol Psychiatry 1: 197-203. World J Biol Psychiatry (2001) 1.39
A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol Psychiatry (2011) 1.38
Tricyclic-induced seizures and absent ECT response. Br J Psychiatry (1994) 1.38
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803). Ann Oncol (2012) 1.36
Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry (2005) 1.34
No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry (1996) 1.28
Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet (1999) 1.27
Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2003) 1.27
Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychol Med (2009) 1.27
Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke (2004) 1.25
Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Br J Cancer (2004) 1.21
Effect of neuroticism, response style and information processing on depression severity in a clinically depressed sample. Psychol Med (2003) 1.20
Differential methylation of the TRPA1 promoter in pain sensitivity. Nat Commun (2014) 1.19
Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF ) after acute psychosocial stress. Transl Psychiatry (2012) 1.17
Polygenic dissection of the bipolar phenotype. Br J Psychiatry (2011) 1.17
Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009. Acta Psychiatr Scand (2012) 1.16
Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry (2012) 1.16
Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry (2005) 1.15
Nutrient content of earthworms consumed by Ye'Kuana Amerindians of the Alto Orinoco of Venezuela. Proc Biol Sci (2003) 1.14
Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type. Psychol Med (2010) 1.13
GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Twin Res (2000) 1.10
Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer (2004) 1.10
Separation of genetic influences on attention deficit hyperactivity disorder symptoms and reaction time performance from those on IQ. Psychol Med (2009) 1.10
The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport (1996) 1.10
The relationship between ADHD and key cognitive phenotypes is not mediated by shared familial effects with IQ. Psychol Med (2010) 1.10
Prenatal life and post-natal psychopathology: evidence for negative gene-birth weight interaction. Psychol Med (2002) 1.09
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess (2009) 1.08
Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer (2000) 1.08
Genetic variation analysis within and among Chinese indigenous swine populations using microsatellite markers. Anim Genet (2002) 1.08
Morbid risk of schizophrenia in first-degree relatives of white and African-Caribbean patients with psychosis. Br J Psychiatry (1996) 1.08
Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet (2003) 1.07
Allele association studies with SSR and SNP markers at known physical distances within a 1 Mb region embracing the ALDH2 locus in the Japanese, demonstrates linkage disequilibrium extending up to 400 kb. Hum Mol Genet (2000) 1.07
Application of laser capture microdissection and proteomics in colon cancer. Mol Pathol (2001) 1.07
Phenotypic and population differences in the association between CILP and lumbar disc disease. J Med Genet (2007) 1.07
Family history as a predictor of poor long-term outcome in depression. Br J Psychiatry (1998) 1.07
Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med (2009) 1.05
MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol (2011) 1.05
Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Hum Genet (1997) 1.05
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res (1998) 1.05
Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry (2004) 1.05
Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism. Genes Brain Behav (2008) 1.05
A genome-wide association study of attempted suicide. Mol Psychiatry (2011) 1.04
HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med (2013) 1.04
Amino acid, mineral and fatty acid content of pumpkin seeds (Cucurbita spp) and Cyperus esculentus nuts in the Republic of Niger. Plant Foods Hum Nutr (2006) 1.04